Madryn Asset Management
Madryn Asset Management, LP is a private equity firm established in 2017 and located in New York, New York. The firm focuses on investments in the healthcare sector, specifically targeting innovative companies that offer unique and transformative products, technologies, and services. Madryn Asset Management leverages its extensive experience in both investment management and healthcare to identify attractive economic opportunities. Utilizing a rigorous independent research process grounded in original insights, the firm aims to achieve strong risk-adjusted and absolute returns for its limited partners while fostering long-term value for its portfolio companies. As a Registered Investment Adviser, Madryn Asset Management is committed to supporting the growth and development of the healthcare technology landscape.
Venus Concept
Post in 2025
Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, that develops and commercializes minimally invasive and non-invasive devices for aesthetic and hair restoration procedures. Its product portfolio includes a range of advanced systems, such as Venus Versa, a multi-treatment platform designed for various aesthetic procedures; Venus Legacy, which addresses challenging facial and body aesthetic concerns; and Venus Fiore, focused on internal vaginal health restoration. Additionally, the company offers Venus Viva for customizable skin resurfacing, Venus Freeze Plus for non-invasive skin tightening, and Venus Bliss for fat reduction. For hair restoration, Venus Concept provides NeoGraft, an automated system for follicle harvesting, along with ARTAS and ARTAS iX robotic systems. The company primarily generates its revenue from the United States, driven by a team of experienced executives and researchers dedicated to enhancing the medical aesthetics industry.
Venus Concept
Post in 2024
Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, that develops and commercializes minimally invasive and non-invasive devices for aesthetic and hair restoration procedures. Its product portfolio includes a range of advanced systems, such as Venus Versa, a multi-treatment platform designed for various aesthetic procedures; Venus Legacy, which addresses challenging facial and body aesthetic concerns; and Venus Fiore, focused on internal vaginal health restoration. Additionally, the company offers Venus Viva for customizable skin resurfacing, Venus Freeze Plus for non-invasive skin tightening, and Venus Bliss for fat reduction. For hair restoration, Venus Concept provides NeoGraft, an automated system for follicle harvesting, along with ARTAS and ARTAS iX robotic systems. The company primarily generates its revenue from the United States, driven by a team of experienced executives and researchers dedicated to enhancing the medical aesthetics industry.
Venus Concept
Venture Round in 2017
Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, that develops and commercializes minimally invasive and non-invasive devices for aesthetic and hair restoration procedures. Its product portfolio includes a range of advanced systems, such as Venus Versa, a multi-treatment platform designed for various aesthetic procedures; Venus Legacy, which addresses challenging facial and body aesthetic concerns; and Venus Fiore, focused on internal vaginal health restoration. Additionally, the company offers Venus Viva for customizable skin resurfacing, Venus Freeze Plus for non-invasive skin tightening, and Venus Bliss for fat reduction. For hair restoration, Venus Concept provides NeoGraft, an automated system for follicle harvesting, along with ARTAS and ARTAS iX robotic systems. The company primarily generates its revenue from the United States, driven by a team of experienced executives and researchers dedicated to enhancing the medical aesthetics industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.